MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Investment Ideas Pro

Is Protagenic Therapeutics (PTIX) Poised for a Breakthrough in Neuropsychiatric Treatment

1 day ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Is EcoSolutions Waste Poised for a Biofuel Breakthrough

1 months ago

Is Arcturus Therapeutics Poised for a Massive Upside in 2026

2 months ago

Is Ionis Pharmaceuticals Poised for a Breakthrough with Tryngolza

2 months ago

Is Rhythm Pharmaceuticals Poised for a Breakthrough in Hypothalamic Obesity

2 months ago

Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer

Pasithea Therapeutics (NASDAQ: KTTA) appointed Kartik Krishnan, M.D., Ph.D., as Chief Medical Officer, effective May 4, 2026. The move adds clinical leadership to the company as it continues developme...

KTTA

Stock News•5 days ago

ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook

ClearPoint Neuro shares have faced significant downward pressure recently, driven by lowered 2026 revenue guidance and ongoing regulatory uncertainty. Despite these near-term headwinds, the company ma...

CLPT

Stock News•6 days ago

Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia

Nexalin reported statistically significant improvements in sleep quality for chronic insomnia patients using its 15 mA, 77.5 Hz neurostimulation therapy. The peer-reviewed study, published in Psychoth...

NXL

Stock News•1 week ago

BioXcel Therapeutics Preps IGALMI At-Home Launch Ahead of Nov. 14 FDA Label Decision

BioXcel Therapeutics is preparing for the potential at-home launch of IGALMI, pending an FDA decision on an expanded label for treating acute agitation. The company expects a regulatory ruling by the ...

BTAI